While expression of miR-146a is increased in normal mammary epithelial cells, it is decreased in primary breast cancers, relieving miR-146-induced inhibition of STAT3 expression, which could exert its oncogenic functions in breast cancer cells [256]. This evidence concerns the gene STAT3 and breast carcinoma.